- Open Access
Whole-genome sequencing reveals transmission of vancomycin-resistant Enterococcus faecium in a healthcare network
- Hayley J. Brodrick†1Email author,
- Kathy E. Raven†1,
- Ewan M. Harrison1,
- Beth Blane1,
- Sandra Reuter1,
- M. Estée Török1, 2, 3,
- Julian Parkhill4 and
- Sharon J. Peacock1, 2, 4, 5
© Brodrick et al. 2016
- Received: 4 September 2015
- Accepted: 29 December 2015
- Published: 12 January 2016
Bacterial whole-genome sequencing (WGS) has the potential to identify reservoirs of multidrug-resistant organisms and transmission of these pathogens across healthcare networks. We used WGS to define transmission of vancomycin-resistant enterococci (VRE) within a long-term care facility (LTCF), and between this and an acute hospital in the United Kingdom (UK).
A longitudinal prospective observational study of faecal VRE carriage was conducted in a LTCF in Cambridge, UK. Stool samples were collected at recruitment, and then repeatedly until the end of the study period, discharge or death. Selective culture media were used to isolate VRE, which were subsequently sequenced and analysed. We also analysed the genomes of 45 Enterococcus faecium bloodstream isolates collected at Cambridge University Hospitals NHS Foundation Trust (CUH).
Forty-five residents were recruited during a 6-month period in 2014, and 693 stools were collected at a frequency of at least 1 week apart. Fifty-one stool samples from 3/45 participants (7 %) were positive for vancomycin-resistant E. faecium. Two residents carried multiple VRE lineages, and one carried a single VRE lineage. Genome analyses based on single nucleotide polymorphisms (SNPs) in the core genome indicated that VRE carried by each of the three residents were unrelated. Participants had extensive contact with the local healthcare network. We found that VRE genomes from LTCF residents and hospital-associated bloodstream infection were interspersed throughout the phylogenetic tree, with several instances of closely related VRE strains from the two settings.
A proportion of LTCF residents are long-term carriers of VRE. Evidence for genetic relatedness between these and VRE associated with bloodstream infection in a nearby acute NHS Trust indicate a shared bacterial population.
- Core Genome
- European Nucleotide Archive
- Healthcare Network
- Bloodstream Isolate
- Hospital Isolate
Over the last decade the introduction of a series of infection control initiatives in acute healthcare environments in the UK has been associated with a dramatic decline in nosocomial infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile [1, 2]. By contrast, the prevalence of bacteraemia caused by vancomycin-resistant enterococci (VRE) has been more resistant to change. Voluntary surveillance in England, Wales and Northern Ireland shows that bacteraemia caused by vancomycin-resistant Enterococcus faecium rose from 16 % to 24 % between 2010 and 2014 , with a similar increase observed across Europe . VRE infections are associated with increased morbidity, mortality, healthcare costs and duration of hospital stay compared with vancomycin-susceptible (VSE) infections [4, 5].
Accurate identification of VRE reservoirs and transmission routes provides strategic direction to infection control interventions. Individuals in long-term care facilities (LTCF) frequently move through healthcare networks and are potential reservoirs for VRE [6, 7]. Pathogen transmission between people in long-term residential and acute care facilities is likely to be common , but investigation is hampered by the low resolution of current typing methods, which cannot distinguish between isolates belonging to the same clone [9, 10]. Whole-genome sequencing (WGS) offers improved resolution, and has been used to delineate pathogen transmission of a range of bacterial species at local, national and global scales [11–14]. WGS also provides the sensitivity to detect genetic diversity of the same clone in an individual [15, 16]. Despite a growing body of data, microbial WGS has not been used to capture a dynamic picture of VRE carriage and transmission within and between interconnected healthcare facilities over time. The aim of this study was to define VRE carriage by residents of a LTCF over a 6-month period, and to use WGS to describe the genetic relatedness of isolates within and between residents, document whether VRE was transmitted in the LTCF over time, and compare these data with the genomes of bloodstream isolates in patients in the nearby acute hospital.
Study design, setting and participants
We conducted a prospective observational cohort study of faecal VRE carriage in residents of a LTCF over a 6-month period in Cambridge, United Kingdom (UK). The LTCF had 105 beds and was subdivided into five physically separated units, to which residents were assigned based on cognitive impairment and physical disability.
Ethics, consent and permissions
All residents admitted to the LTCF during the study period were eligible for inclusion. Residents were excluded if they refused consent, were on an end-of-life care pathway, or were strongly resistant to basic personal care. Written informed consent was obtained from study participants prior to enrolment. For participants who lacked mental capacity, we obtained assent from their consultee. The study protocol was approved by the National Research Ethics Service (REC ref: 13/LO/1278) and the Cambridge University Hospitals NHS Foundation Trust Research and Development department (ref: A093007). All study procedures were performed in accordance with the Declaration of Helsinki.
Data were collected from medical records and nursing care plans. This included demographics (age, gender, unit of residence), presence of co-morbidities (Charlson co-morbidity Index), presence of urinary or faecal incontinence or a urinary catheter, a history of VRE carriage or infection in the 12 months prior to enrolment, and infection and antibiotic use during the study. Data were also collected on healthcare contact (inpatient admission, outpatient clinic attendance, or general practitioner (GP) surgery visit) in the 12 months prior to enrolment and during the study period. Stool samples were collected at recruitment and then repeatedly (up to once a week) until the end of the study period, discharge from the LTCF or death.
Stool samples were cultured within 24 h of collection on Monday to Friday, or within 48 h if collected at weekends. A 10 μL loopful was added to 5 mL Brain-Heart Infusion Broth (BHI) (Merck, Darmstadt, Germany) containing 3 μg/mL vancomycin (Sigma-Aldrich, St Louis, MO, US) and incubated at 37 °C in air at 100 rpm for 24 h. A total of 200 μL was plated onto Brilliance VRE agar (Oxoid, Basingstoke, UK) and incubated at 37 °C for 48 h. Purple or blue colonies (putative E. faecium or E. faecalis, respectively) were sub-cultured on Columbia Blood agar (CBA, Oxoid, Basingstoke, UK), incubated at 37 °C for 48 h, and the species confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) (Bruker Daltoniks, Bremen, Germany). Antimicrobial susceptibility was determined using the Vitek2 instrument (BioMérieux, Marcy l’Etoile, France) and the AST-P607 card. All stools positive for VRE were cultured for VSE. A 10 μL loopful was plated onto Brilliance UTI agar (Oxoid, Basingstoke, UK). Presumptive enterococci were sub-cultured on CBA containing a 5 μg vancomycin disc (Oxoid, Basingstoke, UK). Colonies growing at the edge of the zone of inhibition were selected for identification and antimicrobial susceptibility testing as above.
Bacterial sequencing and analysis
Genomic DNA was extracted from a pure bacterial culture based on a single colony using the QIAxtractor (QIAgen, Hilden, Germany). Library preparation was based on the Illumina protocol, and sequencing was performed on an Illumina HiSeq2000 with 100-cycle paired-end runs. Sequence reads were assembled using Velvet and mapped to the E. faecium reference genome Aus0004 (European Nucleotide Archive (ENA) accession number CP003351) using SMALT . Mobile genetic elements (MGEs) were identified (genes annotated as plasmid-, phage-, IS- or transposon-associated) and removed. Gubbins was used to remove regions of recombination , creating a core genome. Core genome single nucleotide polymorphisms (SNPs) were used to estimate maximum likelihood trees using RAxML  with 100 bootstraps and a midpoint root. The multilocus sequence type (ST) was derived from sequence data using an in-house script and the MLST database . vanA and vanB were detected by in silico polymerase chain reaction (PCR) using published primers [21, 22]. Isolates positive for vanA were mapped to a Tn1546 reference (ENA accession number M97297). The nucleotide sequences of the Tn1546 transposon, and those up- and downstream of the transposon, in each isolate were identified as described by Howden et al.  using Artemis , and queried against each other and nucleotide databases using BLAST. Isolates positive for vanB were mapped to Aus0004 Tn1549  and up- and downstream nucleotide sequences identified as for vanA. Plasmid replicon (rep) typing was performed using in silico PCR and published primers [26, 27].
Whole-genome sequences were available for 45 E. faecium bloodstream isolates collected between January and December 2012 at the Cambridge University Hospitals NHS Foundation Trust (CUH) (S. Peacock, personal communication). These consisted of the first stored isolate for 45 patients, identified using the diagnostic microbiology laboratory database at CUH. Information on date of isolation and patient location was available. These isolates had been sequenced as part of a previous study, approved by the National Research Ethics Service (REC ref: 12/EE/0439) and the Cambridge University Hospitals NHS Foundation Trust R&D Department (ref: A092685). Sequence data for all study isolates have been submitted to the European Nucleotide Archive with the accession numbers shown in Additional file 1.
Forty-five of the 90 (50 %) eligible residents were recruited. Participants had a median age of 82 years (range, 40–104 years; interquartile range (IQR), 71–87 years), and 29 (64 %) were female. Three participants were lost to follow-up during the study because of death (n = 2) or transfer to another facility (n = 1). The median duration of residence in the study facility at the time of recruitment was 16 months (range, 5 days to 54 months; IQR, 6–41 months). The median Charlson co-morbidity Index was 6 (range, 0–10). Thirty-three (73 %) participants were incontinent of urine and faeces (three of whom had an indwelling urinary catheter), and two (5 %) participants had urinary incontinence alone. One participant (P7) had a history of VRE infection (of the urinary tract) in the 12 months prior to recruitment.
Summary of healthcare contact for 45 study participants
Place of residence before admission to study facility (n, %)
7 (46.7 %)
17 (37.8 %)
21 (15.6 %)
Participants with healthcare contact 12 months before recruitment (n, %)
26 (57.7 %)
Total number of episodes
Median (range) per participant
23/60 (38.3 %)
35/60 (58.3 %)
General practice attendanced
2/60 (3.3 %)
Participants with healthcare contact during study (n, %)
6 (13.3 %)
Total number of episodes
Median (range) per participant
General practice attendanced
Carriage of vancomycin-resistant E. faecium by study participants
A phylogenetic tree for the 51 VRE isolates based on SNPs in the core genome is shown in Fig. 1b. P7 carried four genetically distinct lineages (two of which belonged to ST80), and P15 carried three, with no evidence for carriage of related strains by these two residents. The majority of VRE isolates from P7 and P15 each belonged to a single lineage (18/24 (75 %), and 18/21 (86 %)), with a median pairwise SNP difference within each of these two clusters of 3 (range, 0–6) and 1 (range, 0–6), respectively. P7 and P31 both carried VRE isolates belonging to ST203, but these were genetically distinct (median SNP difference of 74; range, 73–74), excluding transmission between them (Fig. 1b). The VRE-positive participants resided in different units. All three VRE positive participants had healthcare contact in the 12 months prior to the study, including hospital admission (5 episodes), outpatient clinic attendance (3 episodes) or attendance at Accident and Emergency Department without admission (1 episode), and one VRE positive participant (P7) had healthcare contact during the study consisting of four inpatient admissions and five outpatient clinic attendances.
To identify the genomic location of the vanA transposon and its relatedness within and between participants, we analysed the region of sequence adjacent to the transposon in each isolate. This was possible for 30 isolates from the three participants and included four STs (ST80, 117, 203 and 787). The highest match in the blast database predicted that the transposon was present on the pLG1 mega-plasmid (accession numbers HM565234 and HM565172)  for 29/30 isolates, (100 % ID up to 5998 bp) and was adjacent to a gene encoding a cadmium efflux system accessory protein. Blast analysis of the remaining isolate (from P15) gave multiple matches to regions in E. faecium strain DO plasmid 2 (accession number CP003585) , p5753cB (GQ900487) , pS177 (HQ115078) , pF856 (JQ663598)  and pRUM (AF507977) . To analyse the similarity between the putative pLG1 plasmid transposons, sequence reads for the 29 genomes were mapped to a reference vanA transposon. This revealed that the six genomes from P31 isolates shared 100 % identity with the reference, while 23 isolates from P7 were identical with the exception of the same SNP at position 8634. We also characterised variation in plasmids using rep typing, which demonstrated the presence of seven types (10, 11, 14, 17, 18, 20 and pMG1) with a range of 2–7 rep types per isolate. There was variation in the presence of rep types, both within and between individual STs, which extended to variation within the same individual.
Genetic relatedness between vancomycin-resistant and -susceptible E. faecium
All 51 VRE-positive stools were cultured for the presence of VSE, which was identified in 25 (49 %) stools from the three participants (n = 9, 15 and 1 for P7, P15 and P31, respectively). MLST was identified from the sequence data, which assigned the isolates to nine STs. As before, P7 and P15 carried multiple STs: P7 carried ST80, ST117 and ST203 (mirroring the VRE STs in this individual) together with ST127 (a single locus variant of ST80), while P15 carried ST787 and ST18 (mirroring the VRE STs in this individual), together with two STs not represented in the VRE population (ST206 and ST17). By contrast, the VSE carried by P31 was assigned to an ST that was different from their VRE strain (ST328). Rep typing of the VSE isolates revealed the same rep types found in the VRE isolates, with a median of 6 rep types per isolate (range, 2–7). No rep types were specific to VRE or VSE. One phenotypically vancomycin susceptible isolate carried the vanB gene (P15-week(W)12-ST17) based on in silico PCR. This isolate lacked the vanR and vanS genes from whole genome sequence data and from the assembled Tn1549 transposon. Loss of vanR and vanS from the van operon resulting in a susceptible phenotype has been described previously for vanA-positive isolates [32, 34]. A phylogenetic tree of the 51 VRE and 25 VSE isolates based on core genome SNPs is shown in Additional file 2. This showed that the VSE carried by P7 and P15 were closely related to their resident VRE populations demonstrating possible in vivo acquisition or loss of resistance, whilst as expected the VSE carried by P31 was not closely related to their VRE.
Relatedness of E. faecium within a healthcare network
Residents of LTCFs are at increased risk of infection from a range of multidrug-resistant organisms (MDRO) compared with the general population [35, 36]. This may be related to several factors, including frequent healthcare contact and high levels of antibiotic use. Furthermore, LTCF are often akin to a home environment, where screening for MDROs is not routinely performed and isolation of residents may be detrimental to care. The combination of these factors represents a perfect storm for the control of MDRO.
In this study, we focused on carriage and transmission of VRE, a nosocomial pathogen that has remained a persistent problem despite the raft of infection control measures introduced into UK hospitals to reduce the prevalence of MRSA and C. difficile. We found that 7 % of residents carried VRE in their stool on at least one occasion, a finding consistent with previous studies in Israel, Germany and the United States [6, 7, 37]. Our longitudinal study design allowed us to investigate carriage over time. This identified variability in the duration of carriage, with two long-term carriers and one individual who appeared to lose VRE carriage during the study. Intermittent and transient VRE carriage has been described previously [38, 39]. Genome sequencing was used to determine the genetic relatedness of VRE isolates. The advantage of doing so became apparent on comparing this with the results of in silico MLST. Reliance on MLST could have led to an incorrect link being made between two residents (P7 and P31) who both carried VRE ST203 which were not closely related on sequencing.
Sequencing of VSE in VRE-positive participants demonstrated that two individuals carried multiple VSE lineages that were closely related to their VRE isolates. This is consistent with the findings of Howden et al.  that VRE and VSE across the species are not genetically distinct. VSE strains may have gained resistance via horizontal gene transfer from colonising VRE lineages. We identified identical vanA transposons and insertion sites in multiple STs from P7, suggesting possible sharing of the vanA mobile genetic element within patients. Rep types were not distinct between VRE and VSE populations, and varied within STs, suggesting the presence of highly mobile plasmids.
A combination of epidemiological and sequence data allowed us to consider the source of VRE acquisition. While the LTCF environment might be expected to lead to multiple transmission events, there was no evidence for direct transmission of VRE within the study facility. Prior evidence for transmission of VRE in LTCFs is limited, with a single point prevalence study suggesting transmission between 3/188 residents based on pulse field gel electrophoresis . Instead, the source of acquisition may be linked to the frequent interaction with healthcare facilities as two persistent carriers with a history of extensive healthcare contact carried multiple VRE lineages, the majority of which have been associated previously with the healthcare setting based on MLST . This indicates long-term carriage (over 6 months) of hospital-associated lineages in community-based care facilities.
Comparison of WGS data for VRE from the LTCF and the acute hospital to which the participants are referred provided the opportunity to compare the relatedness of isolates drawn from different parts of the same healthcare network. This demonstrated that isolates associated with bloodstream infection were highly related to those carried by the LTCF residents. Direct transmission between the study participants and hospital patients is unlikely, but two of the participants carrying VRE were admitted to the hospital within a relevant timeframe for exposure to the circulating VRE lineages. Furthermore, repeated admission of the study participants represents a mechanism for perpetuation of these lineages. The sequence downstream of the vanA transposon in two of the LTCF isolates was identical to four of five hospital isolates closely related to them, providing further evidence for transmission of VRE from hospitals to community care facilities. Additionally, this region of sequence in the genetically more stable vanB Tn1549 transposon of the LTCF isolate matched those from the hospital also carrying vanB.
Our study has several limitations. First, only half of the residents in the study facility agreed to participate in the study, which may have obscured transmission events between study participants and individuals who were not recruited. Second, we only sequenced a single colony from each stool sample, which may have affected our ability to detect carriage of more than one VRE lineage. However, this risk was mitigated by repeated sampling of individual patients over time, which did demonstrate carriage of multiple lineages in long-term carriers. Evidence for concurrent carriage of multiple HCA lineages of enterococci is limited, but has implications for current screening and WGS techniques based upon single cultures. Finally, we only had access to the genome sequence of bloodstream isolates from the acute hospital, which may not be fully representative of the carriage population in this setting. Despite this, we were still able to provide evidence demonstrating that clones had been shared between the hospital and LTCF.
This study has confirmed that a proportion of residents in a community-based long-term care facility carried VRE in stool, genome sequencing of which demonstrated multiple lineages in some cases but no evidence for transmission between residents. This population frequently requires admission to hospital, where they may acquire nosocomial pathogens as well as transmit existing strains to hospital patients and shed organisms into the environment. A genome comparison of VRE carriage isolates in the LTCF and VRE bloodstream isolates confirmed that VRE in the two populations were highly related. This shared population is likely to reflect two-way transmission. Tackling multidrug-resistant pathogens in hospitals requires an understanding of reservoirs and transmission of bacteria within highly connected healthcare facilities, together with infection control policies that consider this as a continuum.
We gratefully acknowledge the contribution of the staff at the LTCF in sample collection, and thank the patients who agreed to participate. We thank Kirsty Ambridge and Angela Kidney for technical assistance. We are grateful for assistance from the library construction, sequencing and core informatics teams at the Wellcome Trust Sanger Institute. This publication presents independent research supported by the Health Innovation Challenge Fund (WT098600, HICF-T5-342), a parallel funding partnership between the Department of Health and Wellcome Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health or Wellcome Trust. MET is a Clinician Scientist Fellow supported by the Academy of Medical Sciences, The Health Foundation and the NIHR Cambridge Biomedical Research Centre.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2014. http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1205 (accessed 21st April 2015).
- Public Health England. Annual Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli bacteraemia and C. difficile infection data 2013/14. 2014. https://www.gov.uk/government/statistics/mrsa-mssa-and-e-coli-bacteraemia-and-c-difficile-infection-annual-epidemiological-commentary (accessed 10th April 2015).
- Public Health England. Voluntary surveillance of Enterococcus spp. bacteraemia, England, Wales and Northern Ireland: 2014. 2014. https://www.gov.uk/government/publications/enterococcus-spp-bacteraemia-voluntary-surveillance (accessed 7th April 2015).
- Cheah ALY, Spelman T, Liew D, Peel T, Howden BP, Spelman D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19(4):E181–9.PubMedView ArticleGoogle Scholar
- Diaz Granados CA, Zimmer S, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis. Clin Infect Dis. 2005;41:327–33.View ArticleGoogle Scholar
- Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, Moses AE. Vancomycin-resistant Enterococci in long - term care facilities. Infect Control Hosp Epidemiol. 2009;30(8):786–9.PubMedView ArticleGoogle Scholar
- Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care--prevalence and risk factors. Int J Med Microbiol. 2013;303(8):405–9.PubMedView ArticleGoogle Scholar
- Kahvecioglu D, Ramiah K, McMaughan D, Garfinkel S, McSorley VE, Nguyen QN, et al. Multidrug-resistant organism infections in US nursing homes: a national study of prevalence, onset, and transmission across care settings, October 1, 2010-December 31, 2011. Infect Control Hosp Epidemiol. 2014;35 Suppl 3:S48–55.PubMedView ArticleGoogle Scholar
- Reuter S, Ellington MJ, Cartwright EJP, Köser CU, Török ME, Gouliouris T, et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med. 2013;173(15):1397–404.PubMedPubMed CentralView ArticleGoogle Scholar
- Hall BG, Ehrlich GD, Hu FZ. Pan-genome analysis provides much higher strain typing resolution than multi-locus sequence typing. Microbiology. 2010;156(Pt 4):1060–8.PubMedPubMed CentralView ArticleGoogle Scholar
- Snitkin ES, Zelazny AM, Thomas PJ, Stock F, NISC Comparative Sequencing Program, Henderson DK, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116.PubMedPubMed CentralView ArticleGoogle Scholar
- Harris SR, Feil EJ, Holden MTG, Quail MA, Nicker EK, Chantratita N, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science. 2010;327(5964):469–74.PubMedPubMed CentralView ArticleGoogle Scholar
- Török ME, Harris SR, Cartwright EJ, Raven KE, Brown NM, Allison ME, et al. Zero tolerance for healthcare-associated MRSA bacteraemia: is it realistic? J Antimicrob Chemother. 2014;69(8):2238–45.PubMedPubMed CentralView ArticleGoogle Scholar
- Harris SR, Cartwright EJP, Török ME, Holden MTG, Brown NM, Ogilvy-Stuart AL, et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis. 2013;13(2):130–6.PubMedPubMed CentralView ArticleGoogle Scholar
- Golubchik T, Batty EM, Miller RR, Farr H, Young BC, Larner-Svensson H, et al. Within-host evolution of Staphylococcus aureus during asymptomatic carriage. PLoS One. 2013;8(5):61319.View ArticleGoogle Scholar
- Stoesser N, Sheppard AE, Moore CE, Golubchik T, Parry CM, Nget P, et al. Extensive within-host diversity in fecally carried extended-spectrum beta-lactamase-producing Escherichia coli: implications for transmission analyses. J Clin Microbiol. 2015;53(7):2122–31.PubMedPubMed CentralView ArticleGoogle Scholar
- SMALT: Pairwise Sequence Alignment Program. Wellcome Trust Sanger Institute, Hinxton, UK http://www.sanger.ac.uk/science/tools/smalt-0 (accessed 1st June 2015).
- Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43(3):e15.PubMedPubMed CentralView ArticleGoogle Scholar
- Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22(21):2688–90.PubMedView ArticleGoogle Scholar
- Multi Locus Sequence Typing: Enterococcus faecium. Imperial College, London http://efaecium.mlst.net/ (accessed 13th May 2015).
- Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant Enterococci by PCR. J Clin Microbiol. 1995;33(1):24–7.PubMedPubMed CentralGoogle Scholar
- Depardieu F, Perichon B, Courvalin P. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J Clin Microbiol. 2004;42(12):5857–60.PubMedPubMed CentralView ArticleGoogle Scholar
- Howden BP, Holt KE, Lam MM, Seemann T, Ballard S, Coombs GW, et al. Genomic insights to control the emergence of vancomycin-resistant enterococci. MBio. 2013;4(4). doi:10.1128/mBio.00412-13.
- Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, et al. Artemis: sequence visualization and annotation. Bioinformatics. 2000;16(10):944–5.PubMedView ArticleGoogle Scholar
- Lam MMC, Seeman T, Tobias NJ, Chen H, Haring V, Moore RJ, et al. Comparative analysis of the complete genome of an epidemic hospital sequence type 203 clone of vancomycin-resistant Enterococcus faecium. BMC Genomics. 2013;14:595.PubMedPubMed CentralView ArticleGoogle Scholar
- Jensen LB, Garcia-Migura L, Valenzuela AJS, Løhr M, Hasman H, Aerestrup FM. A classification system for plasmids from enterococci and other Gram-positive bacteria. J Microbiol Methods. 2010;2010(80):25–43.View ArticleGoogle Scholar
- Wardal E, Gawryszewka I, Hryniewicz W, Sadowy E. Abundance and diversity of plasmid-associated genes among clinical isolates of Enterococcus faecalis. Plasmid. 2013;2013(70):329–42.View ArticleGoogle Scholar
- Laverde Gomez JA, van Schaik W, Freitas A, Coque T, Weaver KE, Francia MV, et al. A multiresistance megaplasmid pLG1 bearing hyl Efm genomic island in hospital Enterococcus faecium isolates. Int J Med Microbiol. 2011;2011(301):165–75.View ArticleGoogle Scholar
- Qin X, Galloway-Peña JR, Sillanpaa J, Roh JH, Nallapareddy SR, Chowdhury S, et al. Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol. 2012;12:135.PubMedPubMed CentralView ArticleGoogle Scholar
- Li X, Alvarez V, Harper WJ, Wang HH. Identification of a persistent, TA-independent tetracycline resistance-encoding plasmid from a dairy Enterococcus faecium isolate. Appl Environ Microbiol. 2011;77(20):7096–103.PubMedPubMed CentralView ArticleGoogle Scholar
- Halvorsen EM, Williams JJ, Bhimani AJ, Billings EA, Hergenrother PJ. Txe, an endoribonuclease of the enterococcal Axe-Txa toxin-antitoxin system, cleaves mRNA and inhibits protein synthesis. Microbiology. 2011;157(Pt2):387–97.PubMedPubMed CentralView ArticleGoogle Scholar
- Szakacs TA, Kalan L, McConnell MJ, Eshaghi A, Shahinas D, McGeer A. Outbreak of vancomycin-susceptible Enterococcus faecium containing the wild-type vanA gene. J Clin Microbiol. 2014;52(5):1682–6.PubMedPubMed CentralView ArticleGoogle Scholar
- Grady R, Hayes F. Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol Microbiol. 2003;47(5):1419–32.PubMedView ArticleGoogle Scholar
- Coburn B, Low DE, Patel SN, Poutanen SM, Shahinas D, Eshaghi A, et al. Vancomycin-variable Enterococcus faecium: In vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate. J Clin Microbiol. 2014;52(5):1766–7.PubMedPubMed CentralView ArticleGoogle Scholar
- Lucet JC, Grenet K, Armand-Lefevre L, Harnal M, Bouvet E, Regnier B, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol. 2005;26(2):121–6.PubMedView ArticleGoogle Scholar
- Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant Gram-negative bacilli into a tertiary care hospital. Clin Infect Dis. 2005;40:1792–8.PubMedView ArticleGoogle Scholar
- Pop-Vicas AE, Mitchell SL, Kandel R, Schreiber R, D'Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc. 2008;56(7):1276–80.PubMedView ArticleGoogle Scholar
- Roghmann M-C, Qaiyumi S, Schwalbe R, Morris JG. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 1997;18(10):679–80.PubMedView ArticleGoogle Scholar
- Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol. 2001;22(7):437–42.PubMedView ArticleGoogle Scholar
- Wendt C, Krause C, Xander LU, Loffler D, Floss H. Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany. Infect Control Hosp Epidemiol. 1999;42(3):193–200.Google Scholar
- Willems RJL, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol. 2009;4(9):1125–35.PubMedView ArticleGoogle Scholar